SCHEMBL5654888

SCHEMBL5654888

COc1ccccc1NC(=O)OCCN1CCN(c2cnccn2)CC1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HTR4 Q13639 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.54
LMNA P02545 1/20 0.54
KDM4E B2RXH2 2/20 0.53
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
HSD17B10 Q99714 1/20 0.53
NPSR1 Q6W5P4 1/20 0.51
HRH3 Q9Y5N1 4/20 0.51
DRD2 P14416 1/20 0.49
HTR2A P28223 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657438 0.94 HRH3 (0.56) ALDH1A1SMN1; SMN2HTR4L3MBTL1LMNA
SCHEMBL5655631 0.89 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2HTR4L3MBTL1KDM4E
SCHEMBL5657766 0.86 HRH3 (0.56) SMN1; SMN2KDM4EHRH3HTR2AMEN1
SCHEMBL5654284 0.85 KDM4E (0.60) ALDH1A1SMN1; SMN2HTR4L3MBTL1KDM4E
SCHEMBL5654228 0.84 NPSR1 (0.55) ALDH1A1SMN1; SMN2HTR4L3MBTL1TSHR
SCHEMBL5656355 0.83 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2L3MBTL1KDM4EUSP2
SCHEMBL5656910 0.83 HTR4 (0.58) ALDH1A1SMN1; SMN2HTR4L3MBTL1KDM4E
SCHEMBL14457584 0.81 HTR4 (0.60) ALDH1A1SMN1; SMN2HTR4L3MBTL1LMNA
SCHEMBL5655862 0.81 NPSR1 (0.59) ALDH1A1HTR4L3MBTL1TSHRNPSR1
SCHEMBL5656389 0.81 ADRA1D (0.65) LMNAUSP2NPSR1DRD2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C ALDH1A1 1018/4885SMN1; SMN2 3970/4885HTR4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.